BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19377922)

  • 1. Thrombotic microangiopathy syndromes.
    Zakarija A
    Cancer Treat Res; 2009; 148():115-36. PubMed ID: 19377922
    [No Abstract]   [Full Text] [Related]  

  • 2. Current insight into thrombotic thrombocytopenic purpura.
    Verbeke L; Delforge M; Dierickx D
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer.
    George JN; Terrell DR; Vesely SK; Kremer Hovinga JA; Lämmle B
    Presse Med; 2012 Mar; 41(3 Pt 2):e177-88. PubMed ID: 22244728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A patient with SLE-associated thrombotic microangiopathy and non-neutralizing antibodies against ADAMTS13.
    Knecht ME; Mayr M; Ferrari S; Scheiflinger F; Trendelenburg M
    Nephrol Dial Transplant; 2010 May; 25(5):1720-2. PubMed ID: 20118067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange.
    Sullivan MR; Danilov AV; Lansigan F; Dunbar NM
    J Clin Apher; 2015 Oct; 30(5):308-10. PubMed ID: 25413611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmapheresis-refractory thrombotic microangiopathy in a hematopoietic stem cell transplant recipient.
    Vasko R; Groenewold F; Korsten P; Müller GA; Koziolek M
    Ther Apher Dial; 2011 Oct; 15(5):507-9. PubMed ID: 21974708
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombotic microangiopathies: role of ADAMTS-13.
    Adil SN; Karim F
    J Pak Med Assoc; 2012 Feb; 62(2):91-2. PubMed ID: 22755364
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic strategy and thrombotic microangiopathy].
    Sakai N; Wada T
    Nihon Jinzo Gakkai Shi; 2014; 56(7):1082-9. PubMed ID: 25420409
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab.
    Au WY; Ma ES; Lee TL; Ha SY; Fung AT; Lie AK; Kwong YL
    Br J Haematol; 2007 Jun; 137(5):475-8. PubMed ID: 17433026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathy following haematopoietic stem cell transplant.
    Seaby EG; Gilbert RD
    Pediatr Nephrol; 2018 Sep; 33(9):1489-1500. PubMed ID: 28993886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic agents and thrombotic microangiopathy.
    Garcia G; Atallah JP
    J Oncol Pharm Pract; 2017 Mar; 23(2):135-142. PubMed ID: 26854265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombotic microangiopathy with anti-ADAMTS 13 antibodies revealing an acute Q fever].
    Morel N; Berthoux E; Colombe B; Bosseray A; Massot C
    Rev Med Interne; 2012 Nov; 33(11):640-2. PubMed ID: 22986120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumab.
    Morales E; Rabasco C; Gutierrez E; Praga M
    Transpl Int; 2015 Jul; 28(7):878-80. PubMed ID: 25712140
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor.
    Schleinitz N; Ebbo M; Mazodier K; Poullin P; Bernit E; Veit V; Veyradier A; Fakhouri F; Kaplanski G; Harle JR
    Am J Hematol; 2007 May; 82(5):417-8. PubMed ID: 17266057
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombotic Microangiopathy in Cancer.
    Weitz IC
    Semin Thromb Hemost; 2019 Jun; 45(4):348-353. PubMed ID: 31041804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematocrit and C-reactive protein predict treatment response times in ADAMTS13-deficient thrombotic microangiopathy.
    Samia NI; Friedman KD; Gottschall JL; Raife TJ
    J Clin Apher; 2011; 26(3):138-45. PubMed ID: 21462238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature.
    Usui J; Glezerman IG; Salvatore SP; Chandran CB; Flombaum CD; Seshan SV
    Hum Pathol; 2014 Sep; 45(9):1918-27. PubMed ID: 25087655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation syndrome and post-transplant microangiopathy following haploidentical bone marrow transplantation for sickle cell anemia.
    Davies JOJ; Hart AC; De La Fuente J; Bain BJ
    Am J Hematol; 2018 Aug; 93(4):588-589. PubMed ID: 29197110
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombotic microangiopathies and antineoplastic agents.
    Grangé S; Coppo P;
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S109-S113. PubMed ID: 28577731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic microangiopathy secondary to steroid pulse therapy administered for refractory nephrotic syndrome.
    Miyamoto T; Ishikawa Y; Yamamoto J; Yamamura T; Kawata T
    Intern Med; 2013; 52(18):2099-103. PubMed ID: 24042520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.